Kindred Healthcare (NYSE:KND) Revenue Estimate Upwardly Revised

After their recent acquisitions, Kindred Healthcare (NYSE:KND) appears to be get some immediate benefit out of it, and their revenue and earnings should increase in 2011 and 2012.

FBR said, "We have increased our revenue assumption and factored in some additional benefit from Kindred’s recent acquisitions, which have driven an increase in the earnings profile for 2011 and 2012. We are increasing our 2011 revenue estimate to $4.74B and our 2012 revenue estimate to $4.95B, representing 9% and 5% year-over-year revenue growth, respectively. Our 2011 EPS estimate has increased by $0.19 to $1.59, representing 18% year-over-year growth, and our 2012 EPS estimate has increased to $1.76, representing 11% year-over-year growth."

FBR Capital maintains a "Market Perform" rating on Kindred Healthcare, which closed Thursday at $19.18, up $1.62 percent, or 9.23 percent. FBR raised their price target on them from $15 to $17.